Grape King Bio began as a pharmaceutical manufacturer, later developed health food supplements, and established Pro-Partner, a multi-level-marketing subsidiary.
Grape King Biotech develops health foods, energy drinks, and beverages for all ages, backed by a professional R&D team. The company operates an OEM/ODM manufacturing platform with diverse product forms and consulting services.
Grape King Bio expands into Malaysia with health supplements as regional demand for nutrition products increases. The company leverages its Taiwan-based operations to target Southeast Asia’s growing wellness market.
Grape King Bio Probiotics secures recognition in the *2025 Parenting Favorite Brands* survey. The company’s probiotic products for children earn a spot among preferred brands for parents. The survey highlights Grape King’s commitment to child health through probiotic innovation.
Grape King Bio achieves its highest-ever annual sales figures. The health food company also expresses optimism about continued growth in 2024, citing strong market demand for its products.
Grape King Bio’s board approves a cash dividend of NT$6.9 per common share, marking the company’s highest payout in history. The decision reflects strong financial performance for the health food producer. Shareholders will benefit from the record distribution.
Grape King Bio’s board approves a **NT$6.5 cash dividend per common share**, matching last year’s payout. The proposal, pending shareholder approval on May 28, implies a **3.08% dividend yield** based on yesterday’s closing price. The company maintains its dividend policy amid stable market conditions.